Zobrazeno 1 - 10
of 207
pro vyhledávání: '"Violet Esquenazi"'
Publikováno v:
Human Immunology. 69:605-613
The immunoregulatory role of human donor bone marrow cells (DBMC) has been studied extensively in our laboratory using in vitro and ex vivo assays. However, new experimental systems that can overcome the limitations of tissue culture assays but with
Autor:
Joshua Miller, Anne Rosen, Violet Esquenazi, George W. Burke, David Roth, Lissett Tueros, Junichiro Sageshima, Eva Herrada, Gaetano Ciancio, Warren Kupin, Jeffrey J. Gaynor
Publikováno v:
Transplantation. 85:507-516
Background. In a retrospective study of the first 75 primary renal transplant patients given alemtuzumab induction at our center, 20 were African American (27%), 32 were Hispanic (43%), and 23 were non-African American, non-Hispanic (31%). Methods. A
Autor:
Manuel Carreno, Rolando Garcia-Morales, Robert Cirocco, Violet Esquenazi, Anne Rosen, Gary Kleiner, Joshua Miller, Laphalle Fuller, Gaetano Ciancio, Bonnie B. Blomberg, Camillo Ricordi, Jeffrey J. Gaynor, George W. Burke, James M. Mathew
Publikováno v:
Transplantation. 83:1611-1619
Background. We update more favorable 10-year deceased donor kidney transplant survival in 63 recipients infused perioperatively with donor vertebral body bone marrow (DBMC-i) vs. 219 noninfused controls having equivalent immunosuppression and demogra
Autor:
George W. Burke, Anne Rosen, Joshua Miller, Robert Cirocco, Ana Hernandez, Yide Jin, Violet Esquenazi, Laphalle Fuller, Gaetano Ciancio
Publikováno v:
Human Immunology. 68:350-361
Renal transplant rejection and graft versus host reactions between HLA genetically-identical sibling (HLAgi) donor/recipient (D/R) pairs are thought to result from minor histocompatibility antigen (mHAg) disparities. We have compared two methods of m
Autor:
Anne Rosen, Paul I. Terasaki, Joshua Miller, Kazuo Mizutani, Miyuki Ozawa, E. Hamdani, Violet Esquenazi
Publikováno v:
American Journal of Transplantation. 7:1027-1031
Approximately 25% of patients who undergo kidney transplantation develop HLA-specific antibodies, the strength of which has not been previously correlated with graft failure. The strength of these de novo antibodies is investigated in this study. Ser
Autor:
Laphalle Fuller, Gaetano Ciancio, Andreas G. Tzakis, Yide Jin, Joshua Miller, Violet Esquenazi, Bonnie B. Blomberg, Camillo Ricordi, George W. Burke
Publikováno v:
Immunological Investigations. 36:213-232
We have shown in ex vivo studies in donor bone marrow-infused kidney transplant recipients, that chimeric cells of either donor or recipient origin taken from the recipient's bone marrow down-regulated the recipient's cellular immune responses. In th
Autor:
Jeffrey J. Gaynor, Manuel Carreno, David M. Roth, Tatiana Cordovilla, Joshua Miller, Gaetano Ciancio, Robert Cirocco, Andreas G. Tzakis, Warren Kupin, Adela Mattiazzi, Anne Rosen, Violet Esquenazi, James M. Mathew, George W. Burke
Publikováno v:
Transplantation. 80:457-465
Background New trends in immunosuppression in clinical transplantation include the use of antibody induction agents in protocols that emphasize reduction or avoidance of steroids and calcineurin inhibitors. Methods In a randomized trial using three d
Autor:
Yide Jin, Joshua Miller, Anne Rosen, Violet Esquenazi, George W. Burke, Camillo Ricordi, Andreas G. Tzakis, Laphalle Fuller, Gaetano Ciancio
Publikováno v:
Human Immunology. 66:637-643
We have previously reported in laboratory volunteers ( in vitro ) and renal transplant recipients ( ex vivo ) that bone marrow cells (BMC) are potent downregulators of the immune response. Also, the use of alemtuzumab (Campath-1H, C1H) for immunodepl
Autor:
Arie Regev, Violet Esquenazi, Juan Madariaga, Panagiotis Tryphonopoulos, Philip Ruiz, Jang Moon, Amr S. Khaled, David Levi, Caio Nery, Camillo Ricordi, Pablo A. Bejarano, Gennaro Selvaggi, Rolando Garcia-Morales, Seigo Nishida, Gary Kleiner, Joshua Miller, Debbie Weppler, Andreas G. Tzakis, Tomoaki Kato
Publikováno v:
American Journal of Transplantation. 5:608-613
We investigated the role of donor bone marrow cell (DBMC) infusions in immunosuppression withdrawal in adult liver transplantation. Patients enrolled were at least 3 years post-transplantation, with stable graft function. Forty-five (study group: G1)
Autor:
Deborah Weppler, Andreas G. Tzakis, Werviston DeFaria, Tomoaki Kato, Violet Esquenazi, Bonnie B. Blomberg, Manuel Carreno, James M. Mathew, Joshua Miller, S. Santiago
Publikováno v:
Transplantation Proceedings. 37:1375-1378
A number of recent reports in clinical and experimental intestinal transplantation have suggested that the donor lymphocytes present in and around the gastrointestinal system are potent mediators of graft-versus-host (GvH) reactivity and that GvH res